Alto Ingredients posts Q3 2025 results update

Alto Ingredients, Inc. filed a current report to share that it has released its financial results for the three and nine months ended September 30, 2025.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Alto Ingredients, Inc. filed a current report to share that it has released its financial results for the three and nine months ended September 30, 2025. On November 5, 2025, the company issued a press release detailing its results of operations and financial condition for this period. The press release is furnished as Exhibit 99.1 and incorporated by reference, but is not considered filed for liability purposes under the Exchange Act.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Alto Ingredients (ALTO) announce in this 8-K filing?

Alto Ingredients, Inc. disclosed that on November 5, 2025 it issued a press release announcing its results of operations for the three and nine months ended September 30, 2025, which is furnished as Exhibit 99.1.

Does this Alto Ingredients (ALTO) 8-K include detailed financial results?

The 8-K states that Alto Ingredients issued a press release with results of operations for the three and nine months ended September 30, 2025, but the detailed financial figures are contained in the press release filed as Exhibit 99.1, not in the body of the 8-K.

How is the Alto Ingredients (ALTO) press release treated under securities laws?

The press release attached as Exhibit 99.1 is described as furnished, not filed, so it is not deemed filed for purposes of Section 18 of the Exchange Act and is not automatically incorporated into other filings unless specifically stated.

What exhibit numbers are included in Alto Ingredients (ALTO) November 5, 2025 8-K?

The filing lists Exhibit 99.1 as the press release dated November 5, 2025 and Exhibit 104 as the cover page interactive data file formatted as Inline XBRL.

Who signed the November 5, 2025 Alto Ingredients (ALTO) 8-K?

The report was signed on behalf of Alto Ingredients, Inc. by Auste M. Graham, who is identified as Chief Legal Officer and Secretary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/05/2025 - 04:15 PM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 5, 2025

ALTO INGREDIENTS, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware

000-21467

41-2170618

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1300 South Second Street

Pekin, Illinois

61554

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (833) 710-2586

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

ALTO

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On November 5, 2025, Alto Ingredients, Inc. issued a press release announcing certain results of operations for the three and nine months ended September 30, 2025. A copy of the press release is furnished (not filed) as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 2.02 of this Current Report on Form 8-K is not incorporated by reference into any filings of Alto Ingredients, Inc. made under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing unless specifically stated so therein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Number		Description
99.1		Press Release dated November 5, 2025
104		Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 5, 2025	ALTO INGREDIENTS, INC.

	By:	/s/ AUSTE M. GRAHAM
		Auste M. Graham,
		Chief Legal Officer and Secretary

Source: View Original Filing on SEC EDGAR